Paul Héroux has a problem. He believes he has identified a way to control the growth of cancer cells, but he can’t get his ideas into print. “We think we have the Rosetta Stone that will allow us to unravel the intricacies of cancer physiology,” says Héroux, a professor at McGill University in Montreal. Yet, one scientific journal after another has refused to publish what he has found.

Read full article